Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inhaled Drug Dose”

68 trials

Showing 20 of 68 results

Early research (Phase 1)Study completedNCT04564456
What this trial is testing

A Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 34
Early research (Phase 1)Study completedNCT03398421
What this trial is testing

Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT01576718
What this trial is testing

The Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Who this might be right for
Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 889
Early research (Phase 1)Study completedNCT04124094
What this trial is testing

A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT02951312
What this trial is testing

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sunovion Respiratory Development Inc. 12
Testing effectiveness (Phase 2)Study completedNCT01696071
What this trial is testing

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Who this might be right for
Asthma
Boehringer Ingelheim 98
Early research (Phase 1)Study completedNCT04769869
What this trial is testing

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

Who this might be right for
Asthma
AstraZeneca 110
Testing effectiveness (Phase 2)Study completedNCT02948582
What this trial is testing

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sunovion Respiratory Development Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT07397351
What this trial is testing

Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation

Who this might be right for
Coronary Artery Disease
Research Institute of Geroprotective Technologies 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT06618105
What this trial is testing

Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd

Who this might be right for
Mild Asthma
Macleods Pharmaceuticals Ltd 144
Large-scale testing (Phase 3)Study completedNCT00424008
What this trial is testing

Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)

Who this might be right for
Asthma
Organon and Co 722
Early research (Phase 1)Study completedNCT03820180
What this trial is testing

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 34
Not applicableStudy completedNCT01400568
What this trial is testing

Suitability of a Low Dose Lipopolysaccharide (LPS) Inhalation as a Challenge Model

Who this might be right for
Healthy
Fraunhofer-Institute of Toxicology and Experimental Medicine 12
Early research (Phase 1)Study completedNCT04072562
What this trial is testing

Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.

Who this might be right for
Asthma
AstraZeneca 24
Early research (Phase 1)Study completedNCT04546256
What this trial is testing

A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

Who this might be right for
Bioequivalence
Respirent Pharmaceuticals Co Ltd. 14
Early research (Phase 1)Study completedNCT02184767
What this trial is testing

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

Who this might be right for
BiPolar
Teva Branded Pharmaceutical Products R&D, Inc. 30
Early research (Phase 1)Study completedNCT01556607
What this trial is testing

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

Who this might be right for
Drug Safety
MicroDose Therapeutx, Inc 10
Testing effectiveness (Phase 2)Study completedNCT00314509
What this trial is testing

Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Who this might be right for
Asthma
AstraZeneca 240
Early research (Phase 1)UnknownNCT06487416
What this trial is testing

A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 186
Testing effectiveness (Phase 2)Study completedNCT00048009
What this trial is testing

Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

Who this might be right for
Asthma
Hoffmann-La Roche
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation